|
Mr. Young has over 20 years experience in senior commercial general management and development positions in the global pharmaceutical industry. Since 1999 Mr. Young has served as President and Chief Executive Officer of AlphaVax a biotechnology company that is developing a novel vaccine technology. He previously held various management positions with Abbott International and Glaxo and Glaxo Wellcome both internationally and in the United States and led the growth of Glaxo's HIV portfolio. Mr. Young holds a BA and an MBA from Indiana University. | 